NICO Holdings plc (MAL:NICO)

Marinus Pharmaceuticals Cash Flow Statement

Financials in millions MWK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	72,009	30,912	-	9,736	10,004
Depreciation & Amortization	6,080	4,269	3,776	3,864	2,761
Other Amortization	2,258	1,115	1,529	1,533	1,210
Other Operating Activities	-1,781	23,274	-3,963	67,132	52,669
Operating Cash Flow	78,566	59,570	1,342	82,265	66,644
Operating Cash Flow Growth	31.89%	4339.25%	-98.37%	23.44%	98.47%
Capital Expenditures	-15,257	-8,746	-3,661	-5,152	-7,451
Sale of Property, Plant & Equipment	175.07	79.68	61.4	108.23	290.44
Purchase / Sale of Intangible Assets	-9,181	-6,135	-1,213	-	-
Investment in Securities	-23,740	-20,141	-45,465	-112,593	-73,391
Other Investing Activities	72,008	73,571	61,454	45,862	36,521
Investing Cash Flow	23,572	37,902	16,001	-64,124	-34,319
Long-Term Debt Issued	20,513	2,858	-	2,000	765.51
Total Debt Repaid	-8,110	-3,793	-2,887	-2,254	-2,055
Net Debt Issued (Repaid)	12,403	-934.96	-2,887	-253.52	-1,290
Common Dividends Paid	-24,503	-14,467	-4,758	-7,109	-4,606
Other Financing Activities	-	-	-	1,217	-
Financing Cash Flow	-12,100	-15,401	-7,645	-6,145	-5,895
Foreign Exchange Rate Adjustments	778.1	3,786	-1,790	-34.64	-105.84
Net Cash Flow	90,817	85,857	7,908	11,961	26,324
Free Cash Flow	63,309	50,824	-2,319	77,113	59,193
Free Cash Flow Growth	24.57%	-	-	30.27%	99.08%
Free Cash Flow Margin	12.56%	17.50%	-1.13%	36.26%	35.02%
Free Cash Flow Per Share	60.70	48.73	-2.22	73.93	56.75
Cash Interest Paid	3,889	2,387	1,989	1,510	1,529
Cash Income Tax Paid	46,169	25,153	15,686	10,499	9,899
Levered Free Cash Flow	137,115	203,198	138,187	234,677	-738.91
Unlevered Free Cash Flow	213,522	244,697	163,640	235,517	-34.7

Updated Sep 23, 2024. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.